ScholarIQanswers from OpenAlex

Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure

PaperCitations, authors & open-access status

Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure have?

ScholarIQcitation count

Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure has 6,901 citations in the OpenAlex counts ScholarIQ stores.

When was Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure published?

ScholarIQyear

Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure has 2014 year in the ScholarIQ index.

What is the open-access status of Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure?

ScholarIQoa status

Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure has bronze oa status in the ScholarIQ index.

What is the DOI of Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure?

ScholarIQdoi

The DOI for Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure is on the source record.

What is the PMID of Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure?

ScholarIQpmid

The PMID for Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure is on the source record.

What is the OpenAlex record for Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure?

ScholarIQopenalex

The OpenAlex for Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial